RxDoctor Payments Data

Christie Bialowas

Plastic and Reconstructive Surgery · San Antonio, TXNPI 1215135744

Payments from drug & device makers

$3,468in general payments, 2019–2025

Across 27 payments — averaging $128.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$1K
  • Wound Management Technologies, Inc$820
  • Axogen$564
  • Solventum Corporation$243
  • Sientra, Inc.$165
  • AbbVie$123
  • plus $244 from 5 others

What the payments were for

  • Consulting fees$50014%
  • Food & beverage$2,02658%
  • Other$94227%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Integra Lifesciences Corporation6$1,309
Wound Management Technologies, Inc3$820
Axogen8$564
Solventum Corporation2$243
Sientra, Inc.1$165
AbbVie2$123
Kls-martin L.p.1$108
Acera Surgical, Inc.1$63
KCI USA, Inc.1$32
Avita Medical Americas, LLC1$27
Stryker1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,468 in reported general payments places this provider in the 55th percentile of 378 plastic and reconstructive surgery providers in Texas.

See all plastic and reconstructive surgery providers in Texas

Medicare billing

Part B allowed, 2024
$109,696
Medicare patients
94
Services billed
650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl11$33

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →